Phibro Animal Health CorpPAHC
Price$35.87Intrinsic value$32.3710% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $1.5B+17.1% YoYTTM through 31 Mar 2026
Net Income $99.7M+106.6% YoYTTM through 31 Mar 2026
Free Cash Flow $9.9MTTM through 30 Jun 2026

Margins

Current
Gross Margin32.8%
EBITDA Margin16.2%
Operating Margin11.7%
Net Margin6.6%

Returns

26.3%ROE
6.6%ROA
10.6%ROIC

Balance Sheet Health

Debt / Equity2.05x
Current Ratio2.96x
Net Debt$663.4M
Cash & Equivalents$61.4M

Quality Metrics

Altman Z-Score3.03
Piotroski F-Score6 / 9
FCF Margin0.6%
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'20'21'22'23'24'25'26
FY2026: $1.5B
Diluted EPS$2.43TTM
'20'21'22'23'24'25'26
FY2026: $2.43

Dividend

$0.24Per share, FY20260.68%Yield-12.9%5-yr growth

Capital Allocation

R&D Spend$24.6M
Capex Intensity3.9%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.